Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common chronic liver disease worldwide, yet efficient therapeutic approaches are lacking. The advent of glucagon-like peptide-1 receptor (GLP-1R)-based multi-target agonists generated renewed opt...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Online Access: | https://doi.org/10.1186/s13098-025-01870-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|